Exploring mechanisms of FGF signalling through the lens of structural biology

Fibroblast growth factors (FGFs) mediate a broad range of functions in both the developing and adult organism. The accumulated wealth of structural information on the FGF signalling pathway has begun to unveil the underlying molecular mechanisms that modulate this system to generate a myriad of distinct biological outputs in development, tissue homeostasis and metabolism. At the ligand and receptor level, these mechanisms include alternative splicing of the ligand (FGF8 subfamily) and the receptor (FGFR1–FGFR3), ligand homodimerization (FGF9 subfamily), site-specific proteolytic cleavage of the ligand (FGF23), and interaction of the ligand and the receptor with heparan sulphate cofactor and Klotho co-receptor.

[1]  M. Konishi,et al.  Fibroblast growth factor 21 regulates lipolysis in white adipose tissue but is not required for ketogenesis and triglyceride clearance in liver. , 2009, Endocrinology.

[2]  H. Jüppner,et al.  Endocrine Regulation of Phosphate Homeostasis , 2009 .

[3]  J. Gordon,et al.  Reciprocal epithelial-mesenchymal FGF signaling is required for cecal development , 2006, Development.

[4]  S. Kliewer,et al.  Fibroblast Growth Factor-21 Regulates PPARγ Activity and the Antidiabetic Actions of Thiazolidinediones , 2012, Cell.

[5]  Y. Luo,et al.  Structural basis for interaction of FGF-1, FGF-2, and FGF-7 with different heparan sulfate motifs. , 2001, Biochemistry.

[6]  Joseph Schlessinger,et al.  Crystal Structures of Two FGF-FGFR Complexes Reveal the Determinants of Ligand-Receptor Specificity , 2000, Cell.

[7]  W. Hendrickson,et al.  Structural interactions of fibroblast growth factor receptor with its ligands. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[8]  C. MacArthur,et al.  Receptor Specificity of the Fibroblast Growth Factor Family* , 1996, The Journal of Biological Chemistry.

[9]  J. Gallagher.  Heparan sulfate: growth control with a restricted sequence menu. , 2001, The Journal of clinical investigation.

[10]  T. Yoneya,et al.  Mutant FGF-23 responsible for autosomal dominant hypophosphatemic rickets is resistant to proteolytic cleavage and causes hypophosphatemia in vivo. , 2002, Endocrinology.

[11]  B Henrissat,et al.  A classification of glycosyl hydrolases based on amino acid sequence similarities. , 1991, The Biochemical journal.

[12]  L. Quarles,et al.  Skeletal secretion of FGF-23 regulates phosphate and vitamin D metabolism , 2012, Nature Reviews Endocrinology.

[13]  M. Razzaque,et al.  Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex formation , 2009, Proceedings of the National Academy of Sciences.

[14]  T. Fleming,et al.  Determination of ligand-binding specificity by alternative splicing: two distinct growth factor receptors encoded by a single gene. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[15]  K. Losos,et al.  FGF8 can activate Gbx2 and transform regions of the rostral mouse brain into a hindbrain fate. , 1999, Development.

[16]  D. Bar-Sagi,et al.  A Lipid-Anchored Grb2-Binding Protein That Links FGF-Receptor Activation to the Ras/MAPK Signaling Pathway , 1997, Cell.

[17]  J. Thiery,et al.  Role of FGF10/FGFR2b signaling during mammary gland development in the mouse embryo. , 2002, Development.

[18]  Cheol‐Hee Kim,et al.  HtrA1 Is a Novel Antagonist Controlling Fibroblast Growth Factor (FGF) Signaling via Cleavage of FGF8 , 2012, Molecular and Cellular Biology.

[19]  S. R. Datta,et al.  Akt Phosphorylation of BAD Couples Survival Signals to the Cell-Intrinsic Death Machinery , 1997, Cell.

[20]  K. Nakao,et al.  Relevant use of Klotho in FGF19 subfamily signaling system in vivo , 2010, Proceedings of the National Academy of Sciences.

[21]  Y. Yarden,et al.  A confined variable region confers ligand specificity on fibroblast growth factor receptors: implications for the origin of the immunoglobulin fold. , 1992, The EMBO journal.

[22]  N. Itoh,et al.  Evolution of the Fgf and Fgfr gene families. , 2004, Trends in genetics : TIG.

[23]  D. Ornitz,et al.  Lung hypoplasia and neonatal death in Fgf9-null mice identify this gene as an essential regulator of lung mesenchyme. , 2001, Development.

[24]  A. McMahon,et al.  Evidence that FGF8 signalling from the midbrain-hindbrain junction regulates growth and polarity in the developing midbrain. , 1997, Development.

[25]  P. Pollock,et al.  Homodimerization Controls the Fibroblast Growth Factor 9 Subfamily's Receptor Binding and Heparan Sulfate-Dependent Diffusion in the Extracellular Matrix , 2009, Molecular and Cellular Biology.

[26]  P. Leder,et al.  Fibroblast growth factor receptor 2 (FGFR2)-mediated reciprocal regulation loop between FGF8 and FGF10 is essential for limb induction. , 1998, Development.

[27]  Walter Birchmeier,et al.  The Docking Protein Gab1 Is an Essential Component of an Indirect Mechanism for Fibroblast Growth Factor Stimulation of the Phosphatidylinositol 3-Kinase/Akt Antiapoptotic Pathway , 2004, Molecular and Cellular Biology.

[28]  Tadashi Kaname,et al.  Mutation of the mouse klotho gene leads to a syndrome resembling ageing , 1997, Nature.

[29]  Robert J Linhardt,et al.  Insights into the molecular basis for fibroblast growth factor receptor autoinhibition and ligand-binding promiscuity. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[30]  L. Lönn,et al.  Depot-specific expression of fibroblast growth factors in human adipose tissue. , 2002, Obesity research.

[31]  K. Nakao,et al.  Molecular cloning and expression of a novel klotho-related protein , 2000, Journal of Molecular Medicine.

[32]  Robert J Linhardt,et al.  Structural basis by which alternative splicing modulates the organizer activity of FGF8 in the brain. , 2006, Genes & development.

[33]  D. Givol,et al.  Developmental localization of the splicing alternatives of fibroblast growth factor receptor-2 (FGFR2). , 1993, Developmental biology.

[34]  J. Rocheleau,et al.  Dynamics and Distribution of Klothoβ (KLB) and Fibroblast Growth Factor Receptor-1 (FGFR1) in Living Cells Reveal the Fibroblast Growth Factor-21 (FGF21)-induced Receptor Complex* , 2012, The Journal of Biological Chemistry.

[35]  C. MacArthur,et al.  FGF-8 isoforms activate receptor splice forms that are expressed in mesenchymal regions of mouse development. , 1995, Development.

[36]  G. Martin,et al.  The mouse Fgf8 gene encodes a family of polypeptides and is expressed in regions that direct outgrowth and patterning in the developing embryo. , 1995, Development.

[37]  T. Strom,et al.  Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF-23. , 2001, Kidney international.

[38]  P. Pollock,et al.  A crystallographic snapshot of tyrosine trans-phosphorylation in action , 2008, Proceedings of the National Academy of Sciences.

[39]  C. MacArthur,et al.  Genomic structure, mapping, activity and expression of fibroblast growth factor 17 , 1999, Mechanisms of Development.

[40]  M. Ohnishi,et al.  Inactivation of klotho function induces hyperphosphatemia even in presence of high serum fibroblast growth factor 23 levels in a genetically engineered hypophosphatemic (Hyp) mouse model , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[41]  N. Perrimon,et al.  Specificities of heparan sulphate proteoglycans in developmental processes , 2000, Nature.

[42]  Russell B. Fletcher,et al.  FGF8 spliceforms mediate early mesoderm and posterior neural tissue formation in Xenopus , 2006, Development.

[43]  J. Slack,et al.  FGF-8 is associated with anteroposterior patterning and limb regeneration in Xenopus. , 1997, Developmental biology.

[44]  P. Janmey,et al.  MARCKS is an actin filament crosslinking protein regulated by protein kinase C and calcium–calmodulin , 1992, Nature.

[45]  Anjana Rao,et al.  Interaction of calcineurin with substrates and targeting proteins. , 2011, Trends in cell biology.

[46]  S. Brunak,et al.  A Systematic Study of Site-specific GalNAc-type O-Glycosylation Modulating Proprotein Convertase Processing* , 2011, The Journal of Biological Chemistry.

[47]  G. Carpenter,et al.  Phospholipase C-gamma as a signal-transducing element. , 1999, Experimental cell research.

[48]  Cristina M Furdui,et al.  Autophosphorylation of FGFR1 kinase is mediated by a sequential and precisely ordered reaction. , 2006, Molecular cell.

[49]  Y. C. Long,et al.  Hormone-like fibroblast growth factors and metabolic regulation. , 2011, Biochimica et biophysica acta.

[50]  V. Katta,et al.  Human keratinocyte growth factor recombinantly expressed in Chinese hamster ovary cells: isolation of isoforms and characterization of post-translational modifications. , 1998, Protein expression and purification.

[51]  N. Itoh,et al.  Fibroblast growth factors: from molecular evolution to roles in development, metabolism and disease. , 2011, Journal of biochemistry.

[52]  S. Kliewer,et al.  βKlotho is required for fibroblast growth factor 21 effects on growth and metabolism. , 2012, Cell metabolism.

[53]  M. Razzaque,et al.  Conversion of a Paracrine Fibroblast Growth Factor into an Endocrine Fibroblast Growth Factor* , 2012, The Journal of Biological Chemistry.

[54]  S. Kliewer,et al.  Research resource: Comprehensive expression atlas of the fibroblast growth factor system in adult mouse. , 2010, Molecular endocrinology.

[55]  A. Munnich,et al.  FGFR2 mutations in Pfeiffer syndrome , 1995, Nature Genetics.

[56]  M. Greenberg,et al.  Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor , 1999, Cell.

[57]  M. Nagase,et al.  Mutations in Fibroblast Growth Factor Receptor 2 Gene and Craniosynostotic Syndromes in Japanese Children , 1998, The Journal of craniofacial surgery.

[58]  M. Mohammadi,et al.  The FGF family: biology, pathophysiology and therapy , 2009, Nature Reviews Drug Discovery.

[59]  J. Schlessinger,et al.  Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization. , 2000, Molecular cell.

[60]  Peter Tontonoz,et al.  Fat and beyond: the diverse biology of PPARgamma. , 2008, Annual review of biochemistry.

[61]  J. M. Suh,et al.  A PPARγ-FGF1 axis is required for adaptive adipose remodelling and metabolic homeostasis , 2012, Nature.

[62]  B. Olwin,et al.  Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation , 1991, Science.

[63]  D. Givol,et al.  A novel form of FGF receptor‐3 using an alternative exon in the immunoglobulin domain III , 1993, FEBS letters.

[64]  W. Mckeehan,et al.  Exon switching and activation of stromal and embryonic fibroblast growth factor (FGF)-FGF receptor genes in prostate epithelial cells accompany stromal independence and malignancy , 1993, Molecular and cellular biology.

[65]  A. Wilkie.  Bad bones, absent smell, selfish testes: the pleiotropic consequences of human FGF receptor mutations. , 2005, Cytokine & growth factor reviews.

[66]  Masashi Suzuki,et al.  Glycosaminoglycan affinity of the complete fibroblast growth factor family. , 2009, Biochimica et biophysica acta.

[67]  S. Hubbard,et al.  Structural Basis for FGF Receptor Dimerization and Activation , 1999, Cell.

[68]  J. Xu,et al.  Fibroblast growth factor receptor (FGFR) 3. Alternative splicing in immunoglobulin-like domain III creates a receptor highly specific for acidic FGF/FGF-1. , 1994, The Journal of biological chemistry.

[69]  K. Rosenblatt,et al.  Regulation of Fibroblast Growth Factor-23 Signaling by Klotho* , 2006, Journal of Biological Chemistry.

[70]  Nobuyuki Itoh,et al.  Fgf10 is essential for limb and lung formation , 1999, Nature Genetics.

[71]  T. Meitinger,et al.  Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23 , 2000, Nature Genetics.

[72]  J. D. Dunbar,et al.  FGF‐21/FGF‐21 receptor interaction and activation is determined by βKlotho , 2008, Journal of cellular physiology.

[73]  M. Mohammadi,et al.  Crystal Structure of Fibroblast Growth Factor 9 Reveals Regions Implicated in Dimerization and Autoinhibition* , 2001, The Journal of Biological Chemistry.

[74]  D. Danilenko,et al.  Fgf-10 is required for both limb and lung development and exhibits striking functional similarity to Drosophila branchless. , 1998, Genes & development.

[75]  M. Kasuga,et al.  Requirement of fibroblast growth factor 10 in development of white adipose tissue. , 2002, Genes & development.

[76]  S. Nishikawa,et al.  Elbow knee synostosis (Eks): a new mutation on mouse Chromosome 14 , 2002, Mammalian Genome.

[77]  B. Thisse,et al.  Functions and regulations of fibroblast growth factor signaling during embryonic development. , 2005, Developmental biology.

[78]  Christof Niehrs,et al.  Fibroblast growth factor signaling during early vertebrate development. , 2005, Endocrine reviews.

[79]  K. Okawa,et al.  Klotho converts canonical FGF receptor into a specific receptor for FGF23 , 2006, Nature.

[80]  A Bairoch,et al.  Updating the sequence-based classification of glycosyl hydrolases. , 1996, The Biochemical journal.

[81]  Michael Melnick,et al.  FGF10/FGFR2b signaling plays essential roles during in vivo embryonic submandibular salivary gland morphogenesis , 2005, BMC Developmental Biology.

[82]  S. Kliewer,et al.  Tissue-specific Expression of βKlotho and Fibroblast Growth Factor (FGF) Receptor Isoforms Determines Metabolic Activity of FGF19 and FGF21* , 2007, Journal of Biological Chemistry.

[83]  M. Razzaque,et al.  The FGF23–Klotho axis: endocrine regulation of phosphate homeostasis , 2009, Nature Reviews Endocrinology.

[84]  H. Nakamura,et al.  Inductive signal and tissue responsiveness defining the tectum and the cerebellum. , 2001, Development.

[85]  J. Flanagan,et al.  Graded Levels of FGF Protein Span the Midbrain and Can Instruct Graded Induction and Repression of Neural Mapping Labels , 2009, Neuron.

[86]  Annik Prat,et al.  The biology and therapeutic targeting of the proprotein convertases , 2012, Nature Reviews Drug Discovery.

[87]  Richard A. Lang,et al.  Differential Interactions of FGFs with Heparan Sulfate Control Gradient Formation and Branching Morphogenesis , 2009, Science Signaling.

[88]  S. Pawlowski,et al.  Fibroblast growth factor 2 control of vascular tone , 1998, Nature Medicine.

[89]  M. Mohammadi,et al.  Structural basis by which alternative splicing confers specificity in fibroblast growth factor receptors , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[90]  M. Kan,et al.  Ligand-specific Structural Domains in the Fibroblast Growth Factor Receptor (*) , 1995, The Journal of Biological Chemistry.

[91]  K. Rosenblatt,et al.  βKlotho is required for metabolic activity of fibroblast growth factor 21 , 2007, Proceedings of the National Academy of Sciences.

[92]  H. Yamada,et al.  Immunohistochemical localization of Klotho protein in brain, kidney, and reproductive organs of mice. , 2004, Cell structure and function.

[93]  S. Kliewer,et al.  Molecular Insights into the Klotho-Dependent, Endocrine Mode of Action of Fibroblast Growth Factor 19 Subfamily Members , 2007, Molecular and Cellular Biology.

[94]  Jeffrey D. Esko,et al.  Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor , 1991, Cell.

[95]  E. Amaya,et al.  FGF signalling: diverse roles during early vertebrate embryogenesis , 2010, Development.

[96]  J. Rubin,et al.  Keratinocyte growth factor functions in epithelial induction during seminal vesicle development. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[97]  R. Quinton,et al.  Decreased FGF8 signaling causes deficiency of gonadotropin-releasing hormone in humans and mice. , 2008, The Journal of clinical investigation.

[98]  C. Price,et al.  Regulation and action of fibroblast growth factor 17 in bovine follicles. , 2009, The Journal of endocrinology.

[99]  J. Gemel,et al.  Structure and sequence of human FGF8. , 1996, Genomics.

[100]  Y. Hayashizaki,et al.  Identification of a novel mouse membrane-bound family 1 glycosidase-like protein, which carries an atypical active site structure. , 2002, Biochimica et biophysica acta.

[101]  M. Mortimore.  From feast to famine , 1989 .

[102]  M. A. Sutton,et al.  Distinct FGFs promote differentiation of excitatory and inhibitory synapses , 2010, Nature.

[103]  Nobuyuki Itoh,et al.  Biochemical analysis of pathogenic ligand-dependent FGFR2 mutations suggests distinct pathophysiological mechanisms for craniofacial and limb abnormalities. , 2004, Human molecular genetics.

[104]  M. Razzaque,et al.  Klotho Coreceptors Inhibit Signaling by Paracrine Fibroblast Growth Factor 8 Subfamily Ligands , 2012, Molecular and Cellular Biology.

[105]  E. Fuchs,et al.  FGF-7 modulates ureteric bud growth and nephron number in the developing kidney. , 1999, Development.

[106]  A. Winterpacht,et al.  Developmental expression of splicing variants of fibroblast growth factor receptor 3 (FGFR3) in mouse. , 1996, The International journal of developmental biology.

[107]  A Bairoch,et al.  New families in the classification of glycosyl hydrolases based on amino acid sequence similarities. , 1993, The Biochemical journal.

[108]  B. Spencer‐Dene,et al.  An important role for the IIIb isoform of fibroblast growth factor receptor 2 (FGFR2) in mesenchymal-epithelial signalling during mouse organogenesis. , 2000, Development.

[109]  Xiuxia Qu,et al.  Glycosaminoglycan-dependent restriction of FGF diffusion is necessary for lacrimal gland development , 2012, Development.

[110]  H. S. Greene.  On the development of cancer. , 1948, Scientific American.

[111]  S. Werner,et al.  Immunoglobulin Domain. Receptor Forms That Differ in Their Third Underlies the Mechanisms for Generating Genes: a Common Structural Arrangement the Human Fibroblast Growth Factor Receptor , 1990 .

[112]  Y. Frishberg,et al.  Hyperostosis–Hyperphosphatemia Syndrome: A Congenital Disorder of O‐Glycosylation Associated With Augmented Processing of Fibroblast Growth Factor 23 , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[113]  Shaun K Olsen,et al.  Structural basis for fibroblast growth factor receptor activation. , 2005, Cytokine & growth factor reviews.

[114]  T. Strom,et al.  Polypeptide GalNAc-transferase T3 and Familial Tumoral Calcinosis , 2006, Journal of Biological Chemistry.

[115]  J. Esko,et al.  Lacrimal Gland Development and Fgf10-Fgfr2b Signaling Are Controlled by 2-O- and 6-O-sulfated Heparan Sulfate* , 2011, The Journal of Biological Chemistry.

[116]  N. Turner,et al.  Fibroblast growth factor signalling: from development to cancer , 2010, Nature Reviews Cancer.

[117]  Makoto Taiji,et al.  FGF9 monomer/dimer equilibrium regulates extracellular matrix affinity and tissue diffusion , 2009, Nature Genetics.

[118]  S. Kliewer,et al.  Endocrine fibroblast growth factors 15/19 and 21: from feast to famine. , 2012, Genes & development.

[119]  H. Edlund,et al.  Attenuation of FGF signalling in mouse β-cells leads to diabetes , 2000, Nature.

[120]  N. Gotoh.  Regulation of growth factor signaling by FRS2 family docking/scaffold adaptor proteins , 2008, Cancer science.